Target intelligence / Profile preview

SP100 nuclear antigen pseudogene

Molecular classification
Other
01

Overview

SP100 nuclear antigen pseudogene is a noncoding segment of DNA that closely resembles the functional SP100 gene but does not produce a functional protein. Pseudogenes like this typically arise from duplication or retrotransposition events and lack the ability to encode active proteins[3]. The functional SP100 gene encodes a nuclear protein involved in chromatin organization, immune regulation, and antiviral responses[1][2][3]. However, the pseudogene variant ENSG00000270287 does not possess these properties and is not a bona fide molecular target. The entry "SP100 nuclear antigen pseudogene" (ENSG00000270287) refers to a pseudogene, not an active protein-coding gene[3]. As such, it is not considered a therapeutic target, does not have molecular functions, interacting drugs, or clinical roles. The functional gene SP100 (SP100 nuclear antigen, ENSG00000130713) is a zinc finger nuclear protein, but this is distinct from the pseudogene. Functional SP100 has roles in chromatin regulation, immune response, and is implicated in several disease processes[1][2][3].

Beyond the preview

Go deeper on SP100 nuclear antigen pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SP100 nuclear antigen pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call